Elsevier

Tetrahedron

Volume 58, Issue 52, 23 December 2002, Pages 10417-10422
Tetrahedron

A ring-fission/C–C bond cleavage reaction with an N-alkyl-N-methyl-N-[(5-phenyl-1,2,4-oxadiazol-3-yl)methyl]amine

https://doi.org/10.1016/S0040-4020(02)01410-2Get rights and content

Abstract

The reaction of N-(3,4-dichlorophenethyl)-N-methylamine (1) with 3-chloromethyl-5-phenyl-1,2,4-oxadiazole (2) was investigated. Employment of an equimolar amount of 1 and 2 in the presence of potassium carbonate led to the expected tertiary amine 3 (N-[(3,4-dichlorophenyl)ethyl]-N-methyl-N-[(5-phenyl-1,2,4-oxadiazol-3-yl)methyl]amine), whereas an excess of 1 and prolonged reaction time resulted in ring fission of the oxadiazole system in 3 and finally in the formation of N′-benzoyl-N-[(3,4-dichlorophenyl)ethyl]-N-methylguanidine (4) and N,N′-bis[(3,4-dichlorophenyl)ethyl]-N,N′-dimethylmethanediamine (5). The structures of products 35 were determined by means of 1H and 13C NMR-spectroscopy, mass spectrometry and IR-spectroscopy, for 3 (as picrate) and 4 also X-ray structure analysis was employed. A possible mechanism of the reaction pathway leading to compounds 4 and 5 is proposed.

Introduction

In the course of a project directed to the synthesis of potential new sigma-receptor-ligands1a–e of type A, we were interested in compounds containing an oxadiazole ring as heterocyclic partial structure R (Scheme 1). The synthesis of compound A usually was carried out via alkylation of N-(3,4-dichlorophenethyl)-N-methylamine (1) with appropriate chloro- or bromoalkyl substituted hetarenes2 (Scheme 1). Thus, we investigated the reaction of 1 with 3-chloromethyl-5-phenyl-1,2,4-oxadiazole (2) in order to obtain the corresponding oxadiazole derivative of type A (n=1, R=5-phenyl-1,2,4-oxadiazol-3-yl).

Section snippets

Results and discussion

TLC-monitoring the reaction of 2 with two equivalents of amine 1 in toluene/DMF according to a procedure described in Ref. 3 showed—besides educt 1—the gradual formation of an initial reaction product. However, with time a second product occurred and became more and more intensive. After 24 h of reflux, the reaction was stopped and the two reaction products were separated by column chromatography affording as the minor component a yellowish oil and as the main component a colorless solid, which

General

Melting points were determined on a Reichert–Kofler hot-stage microscope and are uncorrected. The IR spectra were recorded on an ATI Mattson Genesis Series FTIR™ spectrophotometer. Mass spectra were recorded either on a Shimadzu QP5050 (EI, 70 eV), a Shimadzu GCMS-QP1000 EX instrument (chemical isonisation, isobutane, temperature of the ion source 180°C, heating rate 80°C/min, 8.10−5 Torr) or on a Finnigan MAT 900S (FAB, matrix: glycerine). The NMR spectra were recorded on a Varian UnityPlus 300

Acknowledgements

We want to express our gratitude to Professor A. Eschenmoser (ETH Zürich) for substantial help regarding the proposed reaction mechanism. Moreover, we thank Professor G. Reznicek and Dr L. Jirovetz for recording the mass spectra.

References (31)

  • Kishimoto, T.; Okabe, T.; Yamada, T.; Matsuda, M.; Kitagawa, T. (Nippon Soda Co.), Eur. Pat. Appl. EP 273,534 (06 Jul...
  • A. Eschalier et al.

    Eur. J. Med. Chem.-Chim. Ther.

    (1983)
  • K.-A. Trumm et al.

    Arzneim.-Forsch./Drug Res.

    (1986)
  • A. Albinati et al.

    Acta Crystallogr. sect. B

    (1978)
  • D. Viterbo et al.

    J. Chem. Soc., Perkin Trans. 2

    (1980)
  • K. Horvath et al.

    THEOCHEM

    (1986)
  • SMART Software Users Guide, version 5.0; Bruker Analytical X-ray Systems: Madison, WI,...
  • SAINT Software Users Guide, version 6.0; Bruker Analytical X-ray Systems: Madison, WI,...
  • J.M. Walker et al.

    Pharmacol. Rev.

    (1990)
    W.D. Bowen

    Pharm. Acta Helv.

    (2000)
    P.J. Gilligan et al.

    Drug News Perspectives

    (1994)
    S.D. Wyrick et al.

    Drugs Future

    (1995)
  • Bowen, W. D.; Hauer, K.; Holzer, W.; Jäger, C.; Langer, T. Manuscript in...
  • L.B. Clapp
  • J.C. Jochims
  • U. Kraatz
  • View full text